Eugen Stermetz
Direttore Finanziario/CFO presso SWISSCOM AG
Patrimonio netto: 96 072 $ in data 30/04/2024
Profilo
Attualmente Eugen Stermetz è Chief Financial Officer presso Swisscom AG. In passato è stato direttore finanziario presso FIBREX Medical, Inc., direttore finanziario presso F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH, direttore finanziario di igeneon Krebs-Immuntherapie Forschungs & Entwicklungs GmbH, direttore finanziario presso SVOX AG e consulente aziendale presso Boston Consulting Group Service GmbH. Eugen Stermetz ha ricevuto un dottorato dall'Università di Vienna e una laurea presso l'Università di San Gallo.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SWISSCOM AG
0.00% | 31/12/2022 | 175 ( 0.00% ) | 96 072 $ | 30/04/2024 |
Posizioni attive di Eugen Stermetz
Società | Posizione | Inizio |
---|---|---|
SWISSCOM AG | Direttore Finanziario/CFO | 01/03/2021 |
Swisscom (Schweiz) AG
Swisscom (Schweiz) AG Major TelecommunicationsCommunications Swisscom (Schweiz) AG engages in the provision of telecommunications, broadcasting, and information technology services. It also specializes in the marketing of products for computer systems, including the design, development, and licensing of software. The company was founded on December 9, 1997 and is headquartered in Bern, Switzerland. | Direttore/Membro del Consiglio | - |
Pensionskasse comPlan | Direttore/Membro del Consiglio | - |
Fastweb SpA
Fastweb SpA Major TelecommunicationsCommunications Fastweb SpA engages in the provision of solutions for internet connectivity. The firm offers a wide range of voice and data services, fixed communication, and mobile to households and businesses. It also constructs fiber optic network infrastructure and adopts internet protocol for voice, data, and video transmission. The company was founded by Silvio Scaglia in September 1999 and is headquartered in Milan, Italy. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Eugen Stermetz
Società | Posizione | Fine |
---|---|---|
SVOX AG
SVOX AG Packaged SoftwareTechnology Services SVOX AG develops speech, voice and language output solutions and related equipment. The company was founded by Volker P. Jantzen, Alexander E. Fries and Bettina Hein in April 2000 and is headquartered in Zurich, Switzerland. | Direttore Finanziario/CFO | 01/01/2011 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Direttore Finanziario/CFO | 01/01/2008 |
Igeneon AG | Direttore Finanziario/CFO | 01/01/2005 |
Boston Consulting Group Service GmbH
Boston Consulting Group Service GmbH Miscellaneous Commercial ServicesCommercial Services Part of BCG Holding Group SCS, Boston Consulting Group Service GmbH is a German company that provides management consulting services. The company is based in Munich, Germany. | Corporate Officer/Principal | - |
FIBREX Medical, Inc.
FIBREX Medical, Inc. Miscellaneous Commercial ServicesCommercial Services FIBREX Medical Inc. is a development stage bio-pharmaceutical company. Its operational affiliate FIBREX Medical Research & Development GmbH was established in Vienna in February 2001. The company was founded to convert high impact scientific discovery into pharmaceutical products for important diseases. The company aims to become a leader in the development and commercialization of pharmaceuticals targeting fundamental mechanisms of inflammation and tissue injury. While inflammation is highly desirable to defend the organism against foreign particles and infections, it can become harmful and destructive if it runs unchecked. Inflammation-based tissue injury is well known as a major component in the pathogenesis and progression of important diseases such as myocardial infarction, septic and hemorrhagic shock, graft rejection, or rheumatoid arthritis. In addition, endothelial dysfunction in inflamed tissues leads to capillary leak and deleterious edema formation, aggravating organ dysfunction. | Direttore Finanziario/CFO | - |
Formazione di Eugen Stermetz
University of Vienna | Doctorate Degree |
University of St. Gallen | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SWISSCOM AG | Communications |
Aziende private | 9 |
---|---|
igeneon Krebs-Immuntherapie Forschungs & Entwicklungs GmbH
igeneon Krebs-Immuntherapie Forschungs & Entwicklungs GmbH BiotechnologyHealth Technology igeneon Krebs-Immuntherapie Forschungs & Entwicklungs GmbH develops biological products to treat cancer and other diseases. It focuses on cancer immunotherapies designed to prevent or delay the formation of metastases in cancer of epithelial origin, including colorectal, breast and lung cancer. Founded in 1999, the company is headquartered in Vienna, Austria. | Health Technology |
FIBREX Medical, Inc.
FIBREX Medical, Inc. Miscellaneous Commercial ServicesCommercial Services FIBREX Medical Inc. is a development stage bio-pharmaceutical company. Its operational affiliate FIBREX Medical Research & Development GmbH was established in Vienna in February 2001. The company was founded to convert high impact scientific discovery into pharmaceutical products for important diseases. The company aims to become a leader in the development and commercialization of pharmaceuticals targeting fundamental mechanisms of inflammation and tissue injury. While inflammation is highly desirable to defend the organism against foreign particles and infections, it can become harmful and destructive if it runs unchecked. Inflammation-based tissue injury is well known as a major component in the pathogenesis and progression of important diseases such as myocardial infarction, septic and hemorrhagic shock, graft rejection, or rheumatoid arthritis. In addition, endothelial dysfunction in inflamed tissues leads to capillary leak and deleterious edema formation, aggravating organ dysfunction. | Commercial Services |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Health Technology |
SVOX AG
SVOX AG Packaged SoftwareTechnology Services SVOX AG develops speech, voice and language output solutions and related equipment. The company was founded by Volker P. Jantzen, Alexander E. Fries and Bettina Hein in April 2000 and is headquartered in Zurich, Switzerland. | Technology Services |
Boston Consulting Group Service GmbH
Boston Consulting Group Service GmbH Miscellaneous Commercial ServicesCommercial Services Part of BCG Holding Group SCS, Boston Consulting Group Service GmbH is a German company that provides management consulting services. The company is based in Munich, Germany. | Commercial Services |
Swisscom (Schweiz) AG
Swisscom (Schweiz) AG Major TelecommunicationsCommunications Swisscom (Schweiz) AG engages in the provision of telecommunications, broadcasting, and information technology services. It also specializes in the marketing of products for computer systems, including the design, development, and licensing of software. The company was founded on December 9, 1997 and is headquartered in Bern, Switzerland. | Communications |
Pensionskasse comPlan | |
Igeneon AG | |
Fastweb SpA
Fastweb SpA Major TelecommunicationsCommunications Fastweb SpA engages in the provision of solutions for internet connectivity. The firm offers a wide range of voice and data services, fixed communication, and mobile to households and businesses. It also constructs fiber optic network infrastructure and adopts internet protocol for voice, data, and video transmission. The company was founded by Silvio Scaglia in September 1999 and is headquartered in Milan, Italy. | Communications |
- Borsa valori
- Insiders
- Eugen Stermetz